| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1565 | 2016 |
| A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass RG Moore, DS McMeekin, AK Brown, P DiSilvestro, MC Miller, WJ Allard, ... Gynecologic oncology 112 (1), 40-46, 2009 | 1289 | 2009 |
| An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation EM Hylek, SJ Skates, MA Sheehan, DE Singer New England Journal of Medicine 335 (8), 540-546, 1996 | 1201 | 1996 |
| Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016 | 1175 | 2016 |
| Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma TA Addona, SE Abbatiello, B Schilling, SJ Skates, DR Mani, DM Bunk, ... Nature biotechnology 27 (7), 633-641, 2009 | 1158 | 2009 |
| The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass RG Moore, AK Brown, MC Miller, S Skates, WJ Allard, T Verch, ... Gynecologic oncology 108 (2), 402-408, 2008 | 1149 | 2008 |
| Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009 | 1029 | 2009 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 919 | 2016 |
| Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999 | 734 | 1999 |
| New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005 | 681 | 2005 |
| Osteopontin as a potential diagnostic biomarker for ovarian cancer JH Kim, SJ Skates, T Uede, K Wong, JO Schorge, CM Feltmate, ... Jama 287 (13), 1671-1679, 2002 | 638 | 2002 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 589 | 2019 |
| Acetaminophen and other risk factors for excessive warfarin anticoagulation EM Hylek, H Heiman, SJ Skates, MA Sheehan, DE Singer Jama 279 (9), 657-662, 1998 | 515 | 1998 |
| The clinical course of osteoporosis in anorexia nervosa: a longitudinal study of cortical bone mass NA Rigotti, RM Neer, SJ Skates, DB Herzog, SR Nussbaum Jama 265 (9), 1133-1138, 1991 | 507 | 1991 |
| Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study1 CD Lehman, C Isaacs, MD Schnall, ED Pisano, SM Ascher, PT Weatherall, ... Radiology 244 (2), 381-388, 2007 | 489 | 2007 |
| Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021 | 461 | 2021 |
| Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass RG Moore, M Jabre-Raughley, AK Brown, KM Robison, MC Miller, ... American journal of obstetrics and gynecology 203 (3), 228. e1-228. e6, 2010 | 417 | 2010 |
| Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry B Ye, DW Cramer, SJ Skates, SP Gygi, V Pratomo, L Fu, NK Horick, ... Clinical cancer research 9 (8), 2904-2911, 2003 | 406 | 2003 |
| Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology SC Mok, J Chao, S Skates, K Wong, GK Yiu, MG Muto, RS Berkowitz, ... Journal of the National Cancer Institute 93 (19), 1458-1464, 2001 | 389 | 2001 |
| Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens DW Cramer, RC Bast Jr, CD Berg, EP Diamandis, AK Godwin, P Hartge, ... Cancer prevention research 4 (3), 365-374, 2011 | 378 | 2011 |
